BP p.l.c.: Transaction in Own Shares
21.02.2022 | DGAP
BP p.l.c.
Transaction in Own Shares
BP p.l.c. (the "Company") announces that on 21 February 2022 it has purchased, in accordance with the authority granted by shareholders at the 2021 Annual General Meeting of the Company, a total of 10,083,227 of its ordinary shares of $0.25 each ("Shares") on the London Stock Exchange and Cboe (UK) as part of the buyback programme announced on 8 February 2022 (the "Programme") and as detailed below:
| London Stock Exchange | Cboe (UK)/BXE | Cboe (UK)/CXE | |
| Number of Shares purchased: | 5,150,000 | 2,933,227 | 2,000,000 |
| Highest price paid per Share (pence): | 393.3500 | 393.3500 | 393.3500 |
| Lowest price paid per Share (pence): | 383.7000 | 383.7000 | 383.7000 |
| Volume weighted average price paid per Share (pence): | 389.3299 | 389.3892 | 389.3782 |
The Company intends to cancel these shares in accordance with the intentions expressed in connection with the authority granted by its shareholders at the Company's 2021 Annual General Meeting.
The schedule below contains detailed information about the purchases made by Citigroup Global Markets Limited (intermediary code: SBILGB2L) on the date of purchase as part of the Programme.
Further enquiries:
bp Investor Relations +44(0) 207 496 4000
Schedule of Purchases
Shares purchased: BP p.l.c. (ISIN CODE: GB0007980591)
Aggregate information:
| Venue | Volume-weighted average price (pence) | Aggregated volume |
| London Stock Exchange | 389.3299 | 5,150,000 |
| Cboe (UK) - BXE | 389.3892 | 2,933,227 |
| Cboe (UK) - CXE | 389.3782 | 2,000,000 |
Individual transactions:
To view details of the individual transactions, please paste the following URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/3387C_1-2022-2-21.pdf
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.